Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about Alpha-Synuclein Pathology: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
Alpha-synuclein pathology represents one of the most critical and intensively studied mechanisms in modern neuroscience, constituting a hallmark of several neurodegenerative diseases collectively termed synucleinopathies[@spillantini2000]. These disorders include Parkinson's disease (PD), dementia w
No AI portrait yet
| Name | Alpha-Synuclein Pathology |
| Key Genes/Proteins | BAG3 |
| Related Pathways | Complement C3/C3Ar Pathway |
Knowledge base pages for this entity
flowchart TD
Alpha_Synuclein_Pathology{{"Alpha-Synuclein Pathology"}}
Oxidative_Stress["Oxidative Stress"]
Alpha_Synuclein_Pathology -->|"causes"| Oxidative_Stress
BAG3(["BAG3"])
BAG3 -->|"protects against"| Alpha_Synuclein_Pathology
Chaperone_Expression("Chaperone Expression")
Alpha_Synuclein_Pathology -->|"correlates with"| Chaperone_Expression
DNA(["DNA"])
Alpha_Synuclein_Pathology -->|"causes"| DNA
Mitochondria("Mitochondria")
Alpha_Synuclein_Pathology -->|"causes"| Mitochondria
Complement_C3_C3Ar_Pathway("Complement C3/C3Ar Pathway")
Complement_C3_C3Ar_Pathway -->|"mediates"| Alpha_Synuclein_Pathology
style Alpha_Synuclein_Pathology fill:#4a148c,stroke:#4fc3f7,stroke-width:3px,color:#fff| Target | Relation | Type | Str |
|---|---|---|---|
| Chaperone Expression | correlates_with | process | 0.85 |
| Source | Relation | Type | Str |
|---|---|---|---|
| BAG3 | protects_against | protein | 0.90 |
| Complement C3/C3Ar Pathway | mediates | pathway | 0.85 |
| parasympathetic pathway | promotes | pathway | 0.70 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Physiological SCFAs may worsen alpha-synuclein pathology thr | 0.550 | neurodegeneration | Do physiological concentrations of SCFAs |
| H2S/butyrate imbalance drives enteric alpha-synuclein pathol | 0.380 | Parkinson's disease | - |
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| Single nucleus RNA-seq and ATAC-seq of postmortem PD brain tissue (n=1 | gene_expression | Parkinson's disease | 0.500 | 0.00 | postmortem_human_tissue | extracted | N/A |
| Individuals with SNCA pathogenic variants reported painful dystonia, l | genetic_association | Parkinson's disease | 0.500 | 0.00 | human | extracted | N/A |
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning Alpha-Synuclein Pathology in their description or question text
No additional research found